Citadel Advisors’s Sensus Healthcare SRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTS
PRCP
VCM
DSCM
MIM
S
GWM
Citadel Advisors's SRTS Position: Q1 2026 in Review
Citadel Advisors sold out of Sensus Healthcare (SRTS) in Q1 2026, closing a stake of 33,459 shares — an estimated $149K sold.
Citadel Advisors first reported a position in SRTS in Q1 2021 and held it in 12 quarters. The position peaked at $1.36M in Q4 2024. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.
- Citadel Advisors reported no remaining Sensus Healthcare position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 33,459 Sensus Healthcare shares in Q1 2026, an estimated $149K.
- Citadel Advisors first reported a position in Sensus Healthcare in Q1 2021 and held it in 12 quarters.
- Citadel Advisors's Sensus Healthcare position peaked at $1.36M in Q4 2024.
- 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.